Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lindsey Shanahan"'
Autor:
Shyam A Patel, Jan Cerny, William K Gerber, Andrew Gillis-Smith, Muthalagu Ramanathan, Sakiko Suzuki, Lloyd Hutchinson, Anne Higgins, Patricia Minehart Miron, Ryan Horgan, Andrea Milano, Christie Perron, Rachel Pransky, Lindsey Shanahan, Karl Simin, Alyssa Tonelli, Jonathan M Gerber
Publikováno v:
Blood. 140:6276-6278
Autor:
Angela Desmond, Muthalagu Ramanathan, Jayde Bednarik, Rajneesh Nath, Neeraj Saini, Imran Puthawala, Glen D. Raffel, Jan Cerny, Zheng Zhou, Lindsey Shanahan, Vanessa Fiorini Furtado, Patricia M. Miron, Bruce A. Woda
Publikováno v:
American Journal of Hematology. 94:209-215
An intensive "5 + 1" regimen, which included bolus high dose cytarabine (HiDAC) at 3 g/m2 once daily over 3 hours on days 1-5 and high dose mitoxantrone (HDM) 80 mg/m2 on day 2, was evaluated in 101 consecutively treated newly diagnosed acute myeloid
Autor:
Jayde Bednarik, Bennett E Vogt, Kriti Mittal, Lindsey Shanahan, Jonathan M. Gerber, Jan Cerny, A. Daniyal Siddiqui, Muthalagu Ramanathan, Xin Wang, Subramony Subramonia-Iyer, Saleem Khanani
Publikováno v:
Blood cells, moleculesdiseases. 85
Background Post-transplant maintenance provides progression-free survival benefit in multiple myeloma (MM). Here we report our institution's experience with elotuzumab-based maintenance following autologous stem cell transplant. Methods We retrospect
Autor:
Sakiko Suzuki, Lindsey Shanahan, Shyam A. Patel, Jan Cerny, Jayde Bednarik, Jonathan M. Gerber, Muthalagu Ramanathan, Andrew Gillis-Smith, Rajneesh Nath, Mingjin Wang
Publikováno v:
Transplantation and Cellular Therapy. 27:S230-S231
Autor:
Jayde Bednarik, Jan Cerny, Muthalagu Ramanathan, Lindsey Shanahan, Natalie Malvik, Jonathan M. Gerber
Publikováno v:
Transplantation and Cellular Therapy. 27:S420-S421
Publikováno v:
BIBM
New York Heart Association (NYHA) Class is an important measure of functional status for heart failure (HF) patients used for clinical documentation, treatment decisions, as well as for eligibility criteria and outcome measures in clinical studies. E
Publikováno v:
Leukemia Research. 94:106384
Autor:
Lindsey Shanahan, William V. Walsh, Aimee R. Kroll-Desrosiers, Natasha Fortier, Andrew M. Evens, Rajneesh Nath, Jan Cerny, Muthalagu Ramanathan, Suyang Hao, Bruce A. Woda, Lloyd Hutchinson, Alan G. Rosmarin, Hongbo Yu, Jayde Bednarik, Bruce A. Barton, Glen D. Raffel, Elizabeth O'Rourke
Publikováno v:
British Journal of Haematology. 160:262-266
Autor:
Lindsey Shanahan, Glen D. Raffel, Vanessa Fiorini Furtado, Rajneesh Nath, Patricia M. Miron, Angela Desmond, Neeraj Saini, Imran Puthawala, Muthalagu Ramanathan, Zheng Zhou, Jan Cerny, Bruce A. Woda, Jayde Bednarik
Publikováno v:
Blood. 132:1430-1430
Introduction In acute myeloid leukemia (AML), dose intensification of "7+3" has not produced improved outcomes. At our center, we evaluated an intensive "5+1" regimen of high dose mitoxantrone (HDM) with high dose cytarabine (HiDAC) in all newly diag
Autor:
Glen D. Raffel, Lindsey Shanahan, Jan Cerny, Austin I. Kim, Neng Yu, Rajneesh Nath, Zheng Zhou, Zeina Al-Mansour, Muthalagu Ramanathan
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S343-S344